ATE279930T1 - Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose - Google Patents

Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose

Info

Publication number
ATE279930T1
ATE279930T1 AT98907760T AT98907760T ATE279930T1 AT E279930 T1 ATE279930 T1 AT E279930T1 AT 98907760 T AT98907760 T AT 98907760T AT 98907760 T AT98907760 T AT 98907760T AT E279930 T1 ATE279930 T1 AT E279930T1
Authority
AT
Austria
Prior art keywords
metal bicarbonate
alkali metal
osteoarthrosis
treatment
aqueous alkaline
Prior art date
Application number
AT98907760T
Other languages
English (en)
Inventor
Russell John Beckett
Original Assignee
Lachlan Family Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5677A external-priority patent/AUPO567797A0/en
Priority claimed from AUPP0608A external-priority patent/AUPP060897A0/en
Application filed by Lachlan Family Pty Ltd filed Critical Lachlan Family Pty Ltd
Application granted granted Critical
Publication of ATE279930T1 publication Critical patent/ATE279930T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98907760T 1997-03-17 1998-03-16 Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose ATE279930T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO5677A AUPO567797A0 (en) 1997-03-17 1997-03-17 An aqueous metal bicarbonate solution and method of use
AUPP0608A AUPP060897A0 (en) 1997-11-28 1997-11-28 An aqueous metal bicarbonate solution and method of use
PCT/AU1998/000168 WO1998041218A1 (en) 1997-03-17 1998-03-16 An aqueous metal bicarbonate solution and method of use

Publications (1)

Publication Number Publication Date
ATE279930T1 true ATE279930T1 (de) 2004-11-15

Family

ID=25645376

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907760T ATE279930T1 (de) 1997-03-17 1998-03-16 Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose

Country Status (7)

Country Link
US (5) US6048553A (de)
EP (2) EP1005351B1 (de)
AT (1) ATE279930T1 (de)
CA (1) CA2283326C (de)
DE (1) DE69827143D1 (de)
NZ (1) NZ500170A (de)
WO (1) WO1998041218A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020051794A1 (en) * 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
US7858602B2 (en) 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US20030228374A1 (en) * 2002-06-07 2003-12-11 Pesacreta Thomas C. Topical treatment for skin irritation
GB0306073D0 (en) * 2003-03-18 2003-04-23 Meffert Uwe Potable mineral water and methods for the production thereof
US20070099186A1 (en) * 2003-05-01 2007-05-03 D Adda Di Fagagna Fabrizio Methods and means for the treatment of disorders associated with cellular senescence
US20070202032A1 (en) * 2004-07-19 2007-08-30 Shell Oil Company Process for Producing Caco3 or Mgco3
EP1838337A4 (de) 2004-12-23 2009-10-28 Arthur M Nonomura Cytochrom-p450-enzymkomplexe und behandlungsverfahren damit
US7321798B2 (en) * 2005-03-31 2008-01-22 Medtronic, Inc. Trans-septal/trans-myocardial ventricular pacing lead
EP1946763B1 (de) * 2005-11-08 2013-08-21 Ajinomoto Co., Inc. Mittel zur förderung der erholung nach einer narkose
US20080317876A1 (en) 2007-05-18 2008-12-25 Saeed Sarkar Use of a magnesium isotope for treating hypoxia and a medicament comprising the same
EP1992339A1 (de) * 2007-05-18 2008-11-19 Saeed Sarkar Verwendung eines Magnesiumisotops zur Behandlung von Hypoxie und Medikament dazu
KR100926027B1 (ko) 2007-12-10 2009-11-11 조성제 탄산수의 제조방법 및 이를 이용하여 제조된 탄산수
US20110005958A1 (en) * 2009-07-09 2011-01-13 Onpharma, Inc. METHODS AND SYSTEMS FOR ADJUSTING THE pH OF MEDICAL BUFFERING SOLUTIONS
US8162917B2 (en) * 2008-05-21 2012-04-24 Onpharma, Inc. Methods and apparatus for buffering anesthetics
US9005437B2 (en) * 2008-09-30 2015-04-14 Paul Michael Pedersen Appliances for the alkalizing of water
US8303566B2 (en) * 2009-07-09 2012-11-06 Onpharma, Inc. Methods and apparatus for buffering parenteral solutions
CA2759664A1 (en) * 2009-04-30 2010-11-04 Unique Global Possibilities Medical Pty Limited Bicarbonate solution for bioavailable magnesium and uses thereof
PL2454012T3 (pl) 2009-07-09 2018-04-30 Onpharma, Inc. Sposób i urządzenie do sterylizacji i przechowywania wkładów z roztworem buforującym
US8585963B2 (en) * 2009-07-09 2013-11-19 Onpharma, Inc. Methods and devices for sterilizing and holding buffering solution cartridges
IL201568A (en) 2009-10-15 2014-05-28 Eitan Dafny Process and facility for creating drinking water enriched with magnesium
EP2371372A1 (de) * 2010-04-01 2011-10-05 Anrold Forbes Verfahren zur Unterstützung der Appetitunterdrückung mittels Alkalimetallen
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat
KR101915330B1 (ko) 2010-11-15 2018-11-05 온파마, 인코포레이티드 유체 이송 동안 배출된 유체를 격리하기 위한 장치 및 방법
US20120279179A1 (en) * 2011-04-26 2012-11-08 Onpharma, Inc. Methods and apparatuses for manufacturing a plurality of cartridges of medical buffering solution with a common ph
DE102012002316A1 (de) * 2012-02-06 2013-08-08 Samson Aktiengesellschaft Stellventil zum Einstellen einer Prozessfluidströmung in einer prozesstechnischen Anlage
US20140158639A1 (en) * 2012-12-12 2014-06-12 Water Stabilization And Revitalization Water stabilization and revitalization
US10702548B2 (en) 2015-03-04 2020-07-07 Joelle Michele Forbes Compositions and methods for treating drug addiction
JP6579948B2 (ja) * 2015-12-24 2019-09-25 株式会社日立ハイテクノロジーズ 生体ポリマを分析するための測定試薬及び分析デバイス
BE1024584B1 (fr) 2017-07-28 2018-04-11 Flamingo Holding Sa Methode et appareil domestique de production d’eau minerale a partir d’une eau de ville
US12480150B2 (en) 2018-06-29 2025-11-25 Viktor Veniaminovich Tets and Georgy Viktorovich TETS Compositions for modulating gut microbiota
US11925703B1 (en) 2022-07-29 2024-03-12 Xellia Pharmaceuticals Aps Liquid composition comprising glucose

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878664A (en) * 1972-11-27 1975-04-22 Cybersol Process for producing a therapeutic composition
CA1017249A (en) * 1973-12-19 1977-09-13 Chemo Drug Company Injectable electrolyte solutions
US4588744A (en) * 1978-09-19 1986-05-13 Mchugh John E Method of forming an aqueous solution of 3-3-Bis(p-hydroxyphenyl)-phthalide
US4489535A (en) * 1980-10-02 1984-12-25 Veltman Preston Leonard Materials and method for preparing dialysis solutions containing bicarbonate ions
US4548817A (en) * 1984-01-20 1985-10-22 Webb-Waring Lung Institute Composition and method for treating mammalian acidosis
CA1264442A (en) * 1984-06-22 1990-01-16 Richard L. Veech Electrolyte solutions and in vivo use thereof
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
FR2625679B1 (fr) * 1988-01-08 1990-02-09 Commin Alix Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales
DK0437274T3 (da) * 1990-01-12 1994-10-10 Bartz Volker Bicarbonat- og calciumholdig infusions- og dialyseopløsning
DD297062A5 (de) * 1990-08-23 1992-01-02 Tks Optimum Gmbh,Dd Verfahren zur herstellung eines neuartigen topischen dermatikums mit antientzuendlicher wirkung
DE4125819A1 (de) * 1991-08-03 1993-02-04 Rolf Prof Dr Med Zander Waessrige loesung und deren verwendung
EP0546728A3 (en) * 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
US5523316A (en) * 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
US5498426A (en) * 1994-10-03 1996-03-12 The Procter & Gamble Company Liquid antacid compositions
US20050255174A1 (en) * 2002-04-05 2005-11-17 Arthur Shelley Process and appratus for use in preparing an aqueous magnesium bicarbonate solution

Also Published As

Publication number Publication date
US20040175437A1 (en) 2004-09-09
US6544561B2 (en) 2003-04-08
EP1005351A4 (de) 2000-09-27
US20030180386A1 (en) 2003-09-25
EP1005351B1 (de) 2004-10-20
US6328997B1 (en) 2001-12-11
DE69827143D1 (de) 2004-11-25
EP1005351A1 (de) 2000-06-07
WO1998041218A1 (en) 1998-09-24
NZ500170A (en) 2001-11-30
CA2283326A1 (en) 1998-09-24
US20020064566A1 (en) 2002-05-30
CA2283326C (en) 2008-05-13
EP1447086A1 (de) 2004-08-18
US6048553A (en) 2000-04-11

Similar Documents

Publication Publication Date Title
DE69827143D1 (de) Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose
EP0786458A3 (de) Derivate und analoge der 2-Deoxy-2,3-didehydro-N-acetyl-Neuraminsäure und ihre Verwendung als antivirale Agentien
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
FI875308A0 (fi) Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet.
AR000960A1 (es) Procedimiento para producir un medicamento inhalable para el tratamiento o prevencion de restenosis arterial.
CA2250819A1 (en) Solution for transperitoneal dialysis
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
SG120493G (en) N-tert-Butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl) isoquinoline-3-carboxamide and asparaginyl derivatives thereof
ATE209922T1 (de) Pharmazeutische zusammensetzung von stickstoffmonoxid
KR0141913B1 (en) Anti-virus agents
FI940659A0 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
JPH035427A (ja) 薬剤組成物
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
JPS6470415A (en) Skin permeable remedy system
MY109531A (en) Effervescent antacid
DE59911256D1 (de) Verfahren zur Herstellung von wässrigen Natriummethioninat-Lösungen und Verwendung dieser Lösungen zur Herstellung eines Granulats
TW337997B (en) Pharmaceutical preparation containing plasminogen activators
BR9205700A (pt) Aperfeiçoamento em um processo para purificar e preservar fator IX derivado de plasma do sangue humano ou outra fonte, processos para a preparação de uma composição terapêutica, e para estabilizar fator IX, solução aquosa de fator IX parcialmente purificado, composição terapêutica e processo para tratar doença de christmas.
JPS56106594A (en) Stabilizing method of plasminogen
HU901617D0 (en) Herbicide compositions containing {[(1,3,5-triazin-2-yl)-amino-carbonyl]-amino-sulfonyl}-benzoic acid esters and process for the preparation of the active ingredients
LV5660A3 (lv) Panemiens pretvirusu lidzekla iegusanai
SI0875248T1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as intra-articular lavage liquid
GR3002835T3 (en) Pharmaceutical compositions containing pentamidine
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
DK492989A (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties